BIOMAT Database Logo BIOMAT Database Logo

[Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex]. 1987

N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000386 AIDS-Related Complex A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS. ARC,Lymphadenopathy Syndrome,AIDS Related Complex,Complex, AIDS-Related,Lymphadenopathy Syndromes,Syndrome, Lymphadenopathy,Syndromes, Lymphadenopathy

Related Publications

N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto
Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS.
January 1987, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology,
N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto
Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
September 1985, Cancer research,
N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto
HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex.
January 1985, Nature,
N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto
[Viral hepatitis and AIDS-associated HTLV III/LAV virus infections in drug addicts].
August 1985, Schweizerische medizinische Wochenschrift,
N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto
[Persistent polyadenopathy syndrome and immunity in parenteral drug addicts infected with HTLV-III].
March 1986, Revista clinica espanola,
N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto
Persistent generalized lymphadenopathy in drug addicts: immunological studies.
January 1986, Bollettino dell'Istituto sieroterapico milanese,
N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto
HTLV-III antibody among Italian drug addicts.
July 1985, Lancet (London, England),
N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto
HTLV-III antibody in Edinburgh drug addicts.
November 1985, Lancet (London, England),
N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto
Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS.
March 1985, JAMA,
N Cascavilla, and E Martini, and L Melillo, and P Musto, and M Nobile, and V M Valori, and G Di Giorgio, and M Carotenuto
[Immunopathology of HTLV III infection in drug addicts].
January 1986, Bollettino dell'Istituto sieroterapico milanese,
Copied contents to your clipboard!